Dimos-Dimitrios Mitsikostas

Real-world effectiveness of fremanezumab for migraine prevention 1:23
Real-world effectiveness of fremanezumab for migraine prevention
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
The future of migraine prevention with CGRP-targeted agents 2:14
The future of migraine prevention with CGRP-targeted agents
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Which treatment is optimal for migraine prevention? 1:40
Which treatment is optimal for migraine prevention?
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Comparing CGRP mAbs with preventive migraine standard of care: a likelihood to help or harm analysis 4:32
Comparing CGRP mAbs with preventive migraine standard of care: a likelihood to help or harm analysis
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Targeting CGRP for migraine prevention: the story so far 2:04
Targeting CGRP for migraine prevention: the story so far
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
The content of VJNeurology is intended for healthcare professionals